Key facts
- It has raised $140K; the latest was Seed Round ($140K) in Nov 2025.
- Notable investors include Antler.
- Status: Privately Held (backing).
Investors
1- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for Evidentia
- ·The full record, as it builds
Funding rounds
No funding rounds for Evidentia are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Evidentia
Operator of a scientific data analysis platform intended for precision medicine and clinical research. The company's platform integrates biomarker discovery, high-throughput sequencing, and advanced analytics, enabling the life sciences and healthcare market to access actionable insights, streamline laboratory workflows, and improve diagnostic and therapeutic outcomes through efficient, interoperable, and user-friendly workflows.
- Sector
- Information Technology
- HQ
- Melbourne, Australia
- Founded
- 2025
- Employees
- 2
- Website
- evidentia.bio/
- Ownership
- Privately Held (backing)
Evidentia doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Evidentia shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Evidentia in its N-PORT filings yet. We sweep new filings monthly.